The San Francisco-based company’s stock fell 38% to $20.89 in extended trading, hitting a new 52-week low. The decline follows a difficult period for the digital healthcare platform, which had already seen its share price retreat 39% over the preceding three months. Investors reacted sharply to a revision in revenue expectations that suggests slowing momentum for the platform.

Revised Guidance and Leadership Transition

Doximity adjusted its full-year sales forecast to a range of $642.5 million to $643.5 million, modifying its previous estimate of $640 million to $646 million. More critically, the company projected current-quarter revenue between $143 million and $144 million. That figure fell significantly short of the $150.4 million expected by analysts polled by FactSet, signaling a cooling in the company’s near-term growth trajectory.

The financial headwind arrives as the company manages a sudden change in its executive ranks. Chief Financial Officer Anna Bryson is taking a temporary medical leave of absence, according to the company statement. Siddharth Sitaram, who was appointed chief accounting officer last month after serving as senior vice president of finance for three years, will step in as interim CFO.